OCUL
OCUL
NASDAQ · Pharmaceuticals

Ocular Therapeutix Inc

$9.99
-0.15 (-1.48%)
As of Sep 20, 10:07 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +467.6% upside
Low Target $44.23
Average Target $56.70
High Target $95.28
Current Price $9.99
Current
$9.99
Target
$56.70
$44.23 $56.70 avg $95.28
Scenario Analysis
Bear Case
$44.23
342.7%
Low target
Base Case
$56.70
+467.6%
Avg target
Bull Case
$95.28
+853.8%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$16.44
-39.2% from high
52-Week Low
$6.23
+60.4% from low
Target vs 52W High
$56.70
+244.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%